A Nomination Committee consisting of members appointed by the three largest shareholders or group of shareholders and the Chairman of the Board of Directors has been formed for Biotage AB in accordance with the principles adopted by the annual general meeting held on 4 June 2020. The Nomination Committee shall, before the Annual General Meeting 2021, prepare proposal for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual General Meeting, election of Auditors, the determination of fees and matters pertaining thereto.
The members of the Nominations Committee are:
Marianne Flink, Chair Nomination Committee, appointed by Swedbank Robur fonder
Jonathan Schönbäck, appointed by ODIN Fonder
Christoffer Geijer, appointed by SEB Investment Management
Torben Jørgensen, Chairman of the Board of Biotage AB
Shareholders wishing to submit a proposal to the Nomination Committee may do so by sending e-mail to the Chairman of the Board of Directors of Biotage AB at: info@biotage.com.
Proposals should, in order to be timely assessed by the Nomination Committee, be submitted no later than seven weeks in advance of the meeting.
The Annual General Meeting 2021 in Biotage will be held on Wednesday, April 28, 2021 at 4:00pm CET in Uppsala. Shareholders who want to have a matter addressed at the Annual General Meeting 2021 must submit such a proposal to the same address as above (subject “Annual General Meeting 2021” for the e-mail and the letter, respectively) seven weeks in advance of the meeting at the latest.
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in Drug Discovery and Development, Analytical Testing and Water and Environmental Testing.
Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.
Our customers span a broad range of market segments including Pharmaceutical, Biotech, Contract Research and Contract Manufacturers as well as Clinical, Forensic and Academic laboratories in addition to organizations focused on Food safety, Clean water and Environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs approx. 500 people worldwide. The Group had sales of SEK 1,101 million in 2019 and our products are sold in more than 70 countries. Biotage share (BIOT) is listed in the Mid Cap segment on the NASDAQ Stockholm.
Copyright © 2021 Biotage
Biotage är ett Globalt Impact Tech företag som är djupt engagerade i att lösa samhällsproblem. Vi erbjuder lösningar för kunders arbetsflöden inom Forskning och Tillverkning av Läkemedel, Analytisk Testning och Vatten- och Miljöanalyser.
Biotage bidrar till hållbar vetenskap och vi strävar efter att göra världen mer hälsosam, grönare och renare för mänskligheten – HumanKind Unlimited.
Våra kunder spänner över ett brett spektrum av marknadssegment från läkemedel, bioteknik, kontraktsforskning och kontraktstillverkning till kliniska, forensiska och akademiska laboratorier liksom organisationer som fokuserar på livsmedelssäkerhet, rent vatten och miljömässig hållbarhet.
Biotage har huvudkontor i Uppsala, Sverige, och har ca 500 anställda världen över.
Koncernen hade en försäljning på 1 101 miljoner kronor 2019 och våra produkter säljs i mer än 70 länder.
Biotage aktie (BIOT) är noterad på NASDAQ Stockholm, Mid Cap.
Copyright © 2020 Biotage
SEL-2EV
Two Channel, Extended Collection Bed, UV Detector